Mr. Bill Hornbuckle has been selected as the honoree for the 2012 JDRF Hope Gala: Art of the Cure being held at Mandalay Bay Resort & Casino on Friday, May 11. All proceeds from the event will go towards funding research to find a cure for type 1 diabetes.
Type 1 diabetes (T1D) is an autoimmune disease in which a person’s pancreas stops producing insulin, a hormone that enables people to get energy from food. It occurs when the body’s immune system attacks and destroys the insulin-producing cells in the pancreas, called beta cells. While its causes are not yet entirely understood, scientists believe that both genetic factors and environmental triggers are involved. Its onset has nothing to do with diet or lifestyle. There is nothing you can do to prevent T1D, and—at present—nothing you can do to get rid of it.
”I’m deeply moved that JDRF has chosen me as their 2012 honoree,” said Bill Hornbuckle. “The number of people of all ages that are impacted by diabetes is quite simply shocking. While we will all come together for one evening in May to raise money to help find a cure, we should all remember every day the important work that JDRF is doing around the world.”
Hornbuckle added: “I am hopeful that you can join us and through your leadership and with our community can continue to help eradicate this devastating disease.”
The Gala, which begins at 6 p.m., will feature a cocktail reception, dinner, exceptional silent and live auctions, and live entertainment featuring Gala Master of Ceremonies, Mr. Clint Holmes. Auction packages include exclusive vacation packages, stunning jewelry, dining experiences, an incredible selection of art, fashion, sports memorabilia, and more.
Table prices range from $3,500 to $25,000 and individual tickets are $350 each. For more information on event details; sponsorship, donation and ticket options; an auction preview; advance registration and volunteer sign-up forms, please visit www.jdrflv.org or contact the JDRF office at 702.732.4795.
About JDRF
JDRF is the leading global organization focused on type 1 diabetes (T1D) research. Driven by passionate, grassroots volunteers connected to children, adolescents, and adults with this disease, JDRF is now the largest charitable supporter of T1D research. The goal of JDRF research is to improve the lives of all people affected by T1D by accelerating progress on the most promising opportunities for curing, better treating, and preventing T1D. JDRF collaborates with a wide spectrum of partners who share this goal.
Since its founding in 1970, JDRF has awarded more than $1.6 billion to diabetes research. Past JDRF efforts have helped to significantly advance the care of people with this disease, and have expanded the critical scientific understanding of T1D. JDRF will not rest until T1D is fully conquered. More than 80 percent of JDRF’s expenditures directly support research and research-related education.
For more information, please visit www.jdrf.org.
